Literature DB >> 27168827

Endothelial nitric oxide synthase gene polymorphism is associated with Legg-Calvé-Perthes disease.

Yulong Zhao1, Shijie Liao1, Rongbin Lu1, Hao Dang1, Jinmin Zhao1, Xiaofei Ding1.   

Abstract

The aim of this study was to assess the association of 27-bp variable number tandem repeat (VNTR) polymorphism in intron 4 and G894T polymorphism in exon 7 of the endothelial nitric oxide synthase (eNOS) gene with Legg-Calvé-Perthes disease (LCPD), and to provide a scientific basis for further research into the pathogenic mechanism. A total of 80 patients with LCPD and 100 healthy subjects were recruited in this case-control study. The 27-bp VNTR and G894T polymorphisms of the eNOS gene were genotyped using polymerase chain reaction (PCR) and PCR-restriction fragment length polymorphism, respectively, followed by agarose gel electrophoresis and DNA sequencing. Allelic and genotypic frequencies were computed in the two groups and subjected to statistical analysis. For the 27-bp VNTR polymorphism, individuals with LCPD showed a higher frequency of the ab genotype [27.5 vs. 14%; odds ratio (OR), 2.33; 95% confidence interval (CI), 1.10-4.92; P=0.024]. For the G894T polymorphism, the LCPD case group showed a higher frequency of the heterozygous genotype GT than the healthy control group (35 vs. 17%; OR, 2.67; 95% CI, 1.33-5.36; P=0.005). The results indicate that these eNOS gene polymorphisms may be a risk factor for LCPD. The 27-bp VNTR polymorphism in intron 4 and G894T polymorphism in exon 7 may be involved in the etiology of LCPD.

Entities:  

Keywords:  Legg-Calvé-Perthes disease; gene polymorphism; nitric oxide synthase

Year:  2016        PMID: 27168827      PMCID: PMC4840501          DOI: 10.3892/etm.2016.3111

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  36 in total

1.  Molecular cloning and characterization of human endothelial nitric oxide synthase.

Authors:  P A Marsden; K T Schappert; H S Chen; M Flowers; C L Sundell; J N Wilcox; S Lamas; T Michel
Journal:  FEBS Lett       Date:  1992-08-03       Impact factor: 4.124

Review 2.  Perthes disease: evaluation and management.

Authors:  Hitesh Shah
Journal:  Orthop Clin North Am       Date:  2013-09-26       Impact factor: 2.472

3.  Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene.

Authors:  P A Marsden; H H Heng; S W Scherer; R J Stewart; A V Hall; X M Shi; L C Tsui; K T Schappert
Journal:  J Biol Chem       Date:  1993-08-15       Impact factor: 5.157

4.  Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease (78-A: 3-13, Jan. 1996)

Authors:  D M Hunt; Z Holmes; W Pickering; H Cohen
Journal:  J Bone Joint Surg Am       Date:  1998-04       Impact factor: 5.284

5.  Intron 4 polymorphism of the endothelial nitric oxide synthase (eNOS) gene is associated with decreased NO production in a mercury-exposed population.

Authors:  Katia Cristina de Marco; Lusania Maria Greggi Antunes; Jose Eduardo Tanus-Santos; Fernando Barbosa
Journal:  Sci Total Environ       Date:  2011-11-30       Impact factor: 7.963

6.  A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese.

Authors:  M Yoshimura; H Yasue; M Nakayama; Y Shimasaki; H Sumida; S Sugiyama; K Kugiyama; H Ogawa; Y Ogawa; Y Saito; Y Miyamoto; K Nakao
Journal:  Hum Genet       Date:  1998-07       Impact factor: 4.132

7.  The role of protein C, protein S, and resistance to activated protein C in Legg-Perthes disease.

Authors:  J Eldridge; A Dilley; H Austin; M EL-Jamil; L Wolstein; J Doris; W C Hooper; P L Meehan; B Evatt
Journal:  Pediatrics       Date:  2001-06       Impact factor: 7.124

8.  Segmental vascular changes in the femoral head in children and adults.

Authors:  A B Ferguson
Journal:  Clin Orthop Relat Res       Date:  1985-11       Impact factor: 4.176

9.  Association of endothelial nitric oxide synthase gene intron 4 polymorphism with end-stage renal disease.

Authors:  Maria H Bellini; Márcia N Figueira; Michelly F Piccoli; Júlio T Marumo; Maysa S Cendoroglo; Miguel C Neto; Maria A Dalboni; Marcelo C Batista; Miguel A Goes; Nestor Schor
Journal:  Nephrology (Carlton)       Date:  2007-06       Impact factor: 2.506

10.  Association of endothelial nitric oxide synthase gene polymorphisms with classical risk factors in development of premature coronary artery disease.

Authors:  T A Abdel-Aziz; R H Mohamed
Journal:  Mol Biol Rep       Date:  2012-12-27       Impact factor: 2.316

View more
  5 in total

1.  Association of eNOS 27-bp VNTR, 894G>T and 786T>C polymorphisms with susceptibility to Legg-Calve-Perthes Disease in Iranian children.

Authors:  Mohammad Reza Azarpira; Mohammad Mahdi Ghilian; Mohammad Reza Sobhan; Masoud Mahdinezhad-Yazdi; Kazem Aghili; Hossein Ahrar; Hossein Neamatzadeh
Journal:  J Orthop       Date:  2019-02-26

Review 2.  Legg-Calvé-Perthes disease overview.

Authors:  Armando O Rodríguez-Olivas; Edgar Hernández-Zamora; Elba Reyes-Maldonado
Journal:  Orphanet J Rare Dis       Date:  2022-03-15       Impact factor: 4.123

3.  Microarray analysis of lncRNA and mRNA expression profiles in patients with Legg-Calve-Perthes disease.

Authors:  Shangyu Wang; Haobo Zhong; Renhao Ze; Pan Hong; Jin Li; Xin Tang
Journal:  Front Pediatr       Date:  2022-09-07       Impact factor: 3.569

4.  Association of Nitric Oxide Levels and Endothelial Nitric Oxide Synthase G894T Polymorphism with Coronary Artery Disease in the Iranian Population.

Authors:  Khalil Mahmoodi; Leila Nasehi; Elham Karami; Mohammad Soleiman Soltanpour
Journal:  Vasc Specialist Int       Date:  2016-09-30

5.  Is Legg-Calvé-Perthes Disease a Local Manifestation of a Systemic Condition?

Authors:  Yasmin D Hailer; Nils P Hailer
Journal:  Clin Orthop Relat Res       Date:  2018-05       Impact factor: 4.176

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.